Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Impact of Red Blood Cell Exchange on Thrombo-inflammation in Sickle Cell Disease STIREX : Sickle Cell Disease - Thrombo-Inflammation - Red Blood Cell EXchange

NCT06769139 is registered in ClinicalTrials.gov with University Hospital, Toulouse as lead sponsor.

NCT NCT06769139
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06769139 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Impact of Red Blood Cell Exchange on Thrombo-inflammation in Sickle Cell Disease STIREX : Sickle Cell Disease - Thrombo-Inflammation - Red Blood Cell EXchange
Lead sponsor
University Hospital, Toulouse
Phase
Observational
Overall status
Not yet recruiting
Start date
January 31, 2025
Completion date
January 31, 2026
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sickle cell disease